Organogenesis Holdings Inc (ORGO)

NASDAQ HEALTHCARE
$2.44 +4.27% RSI 50 Neutral Add Alert

Moving Averages

SMA 200
$3.82
Price below

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$306.25M
P/E Ratio
None
EPS
$-0.12
Beta
1.327
Dividend Yield
0.00%
52-Week High
$7.08
52-Week Low
$2.04

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 64.0
CGC
Canopy Growth Corporation
RSI 37.0
BFRI
Biofrontera Inc
RSI 55.0
TLRY
Tilray Brands Inc - Class 2
RSI 33.0
LNTH
Lantheus Holdings Inc
RSI 63.0
ACB
Aurora Cannabis Inc
RSI 32.0
BCRX
Biocryst Pharmaceuticals Inc
RSI 55.0
INM
InMed Pharmaceuticals Inc
RSI 59.0
ZTS
Zoetis Inc - Class A
RSI 57.0
AQST
Aquestive Therapeutics Inc
RSI 52.0

Data last updated: June 13, 2026 at 3:27 AM EDT

Track ORGO for free

Get e-mail RSI alerts when Organogenesis Holdings Inc enters oversold or overbought territory. Free forever.

Add Alert